Urbanos Garrido, Rosa María

Profile Picture
First Name
Rosa María
Last Name
Urbanos Garrido
Universidad Complutense de Madrid
Faculty / Institute
Ciencias Económicas y Empresariales
Economía Aplicada, Pública y Política
Economía Aplicada
UCM identifierORCIDScopus Author IDDialnet IDGoogle Scholar ID

Search Results

Now showing 1 - 2 of 2
  • Publication
    What to expect from assisted reproductive technologies? Experts' forecasts for the next two decades
    (Elsevier Inc., 2019-08-30) Alon, Ido; Guimón, José; Urbanos Garrido, Rosa María
    In recent years, In-Vitro Fertilization (IVF), Pre-implantation Genetic Diagnosis (PGD) and genetic engineering (GE) have developed substantially, raising hopes but also concerns. Relying on a panel of experts, this article explores expected scenarios related to the evolution of Assisted Reproductive Technologies (ART), thus helping to ascertain which expectations might materialize over the next twenty years. We use the Delphi method, whereby forecasts are extracted from a survey, and combine it with in-depth interviews with experienced doctors and geneticists in Israel and Spain. Our results reveal prospects for an increase in birth rates per InVitro Fertilization (IVF) cycle, an improvement in treatment quality, and advances in reproductive genetics. Experts predict that within 20 years, 14-19% of births in their countries will result from IVF, among which 34-47% will involve PGD. However, they remain skeptic regarding the increase in the number of oocytes required for an expanded PGD, thus skeptic regarding inflated hopes or dystopian scenarios and indicating that GE by CRISPR/Cas could set the tone. We conclude that ART’s market development in the next two decades will continue to be mainly linked to growing infertility rates and improvement in outcomes, while reproductive genetics will advance but remain secondary.
  • Publication
    Regulatory responses to assisted reproductive technology: a comparative analysis of Spain and Israel
    (Springer New York LLC, 2019-07-25) Alon, Ido; Guimón, José; Urbanos Garrido, Rosa María
    Purpose: The market of assisted reproductive technologies (ARTs) is rapidly evolving, raising growing ethical and social dilemmas. This paper compares the regulatory responses to technological and market developments in Israel and Spain, both intensive users of ART. We identify strengths and deficiencies in the regulation of ART in these two countries. Methods: We developed a conceptual framework to classify the factors affecting regulations and priority setting, and applied it using a Delphi survey combined with in-depth interviews. We selected two panels of experts from various fields, trying to simulate the bioethics committees of Israel and Spain. Results: ART is often wrongfully perceived as a solution to age-related infertility. Both panels embraced alternative solutions. The impact of private commercial interest on regulations is resulting in excessive practices such as the repeat of ineffective cycles and the push of sometimes unnecessary treatment add-ons. Our findings show experts dissatisfaction with the regulations of donor-eggs concerning reimbursement and registries in both countries. Conclusions: The adequacy of ART to solve age-related infertility should be confronted with alternative approaches, with emphasis on the distribution of accurate information. The magnitude of ART markets, particularly the use of donor-eggs, should raise the need for additional societal debate and the reform of regulations. The impact factors analysis leads us to question the current regulatory framework, which could be improved by nominating a non-governmental statutory central regulatory agency in Israel and by reforming the Spanish agency. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.